KVUECongressional Stock Trades
Kenvue Inc.
Perfumes, Cosmetics & Other Toilet Preparations
Congressional stock trades in Kenvue Inc. (KVUE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
15
Politicians Trading
8
Last Traded
Aug 5, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Sheldon WhitehouseD | Sep 3, 2025 | Aug 28, 2025 | Sell | $1,001 - $15,000 | -5.99% |
Price History
About Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
8 members of Congress have disclosed 15 trades in Kenvue Inc. (KVUE). Most active: Gilbert Ray Cisneros, Jr. (5), Lisa C. McClain (4), Alan Armstrong (1).
Across all disclosures, members of Congress reported 6 purchases and 9 sales of Kenvue Inc. (KVUE). The most recent trade was on Aug 5, 2026.
Gilbert Ray Cisneros, Jr. disclosed buying Kenvue Inc. (KVUE) on Jun 16, 2026, valued at $1,001 - $15,000.
Kevin Hern disclosed selling Kenvue Inc. (KVUE) on Aug 5, 2026, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.